APA (7th ed.) Citation

MB, O., S, V., M, B., M, v. E., JJ, L. v. B., T, M., . . . PW, P. (2015). Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. MAbs, 7(2), 311. https://doi.org/10.1080/19420862.2015.1007813

Chicago Style (17th ed.) Citation

MB, Overdijk, et al. "Antibody-mediated Phagocytosis Contributes to the Anti-tumor Activity of the Therapeutic Antibody Daratumumab in Lymphoma and Multiple Myeloma." MAbs 7, no. 2 (2015): 311. https://doi.org/10.1080/19420862.2015.1007813.

MLA (9th ed.) Citation

MB, Overdijk, et al. "Antibody-mediated Phagocytosis Contributes to the Anti-tumor Activity of the Therapeutic Antibody Daratumumab in Lymphoma and Multiple Myeloma." MAbs, vol. 7, no. 2, 2015, p. 311, https://doi.org/10.1080/19420862.2015.1007813.